Vancomycin, which has experienced increased usage over the past five years, continues to dominate as a first-line treatment of MRSA infections, according to a Decision Resources and Arlington Medical Resources news release.
AMR analyzed survey data from infectious disease specialists and internists as well as hospital patient-level medical data. Sixty to 76 percent of surveyed infectious disease specialists indicated that they use vancomycin as first-line treatment for bloodstream infections, complicated skin and skin structure infections and hospital-acquired pneumonia suspected to or confirmed to involve MRSA.
Results also showed surveyed infectious disease specialists consider sepsis and prosthetic joint infections to be the most difficult-to-treat indications needing novel anti-MRSA therapies. Additionally, patient-level audit data of drug costs and usage reveal high antibiotic costs for sepsis and prosthetic joint infections due to long treatment duration and use of premium-priced antibiotics.
Read the AMR news release about MRSA treatments.
Related Articles About MRSA:
Patient Safety Tool: Free MRSA Posters and Brochures
Study: Hospital Employees Display Positive Perceptions Toward MRSA Screening Mandates
Study: Antibiotic Linezolid an Effective Treatment for MRSA Infection
AMR analyzed survey data from infectious disease specialists and internists as well as hospital patient-level medical data. Sixty to 76 percent of surveyed infectious disease specialists indicated that they use vancomycin as first-line treatment for bloodstream infections, complicated skin and skin structure infections and hospital-acquired pneumonia suspected to or confirmed to involve MRSA.
Results also showed surveyed infectious disease specialists consider sepsis and prosthetic joint infections to be the most difficult-to-treat indications needing novel anti-MRSA therapies. Additionally, patient-level audit data of drug costs and usage reveal high antibiotic costs for sepsis and prosthetic joint infections due to long treatment duration and use of premium-priced antibiotics.
Read the AMR news release about MRSA treatments.
Related Articles About MRSA:
Patient Safety Tool: Free MRSA Posters and Brochures
Study: Hospital Employees Display Positive Perceptions Toward MRSA Screening Mandates
Study: Antibiotic Linezolid an Effective Treatment for MRSA Infection
